Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis
| Image |  |
|---|---|
| Description | scientific article published on 22 January 2019 |
| Author/s |
author: Douglas Tremblay Elizabeth O. Hexner John Mascarenhas Amylou Dueck Heike L. Pahl |
| Publication date | January 22, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |